Image

Milaberon in Advanced Solid Tumors: an Open, Multicenter Clinical Study

Investigational Medication Study for Participants with Advanced Solid Tumors

Recruiting
18-65 years
All
Phase 2
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates advanced solid tumors. It looks at how the investigational medication works with these tumors.

The study evaluates the safety and effects of the investigational medication on participants with advanced solid tumors.

  • Who can participate: Adults aged 18-65 with advanced solid tumors can participate. Participants should not have had previous systemic treatment for metastatic tumors and must meet specific health criteria such as normal major organ functions. Good compliance and informed consent are required.
  • Study details: Participants will take the investigational medication daily. The study will monitor for side effects like rapid heartbeat and urinary issues.
Print
Study details
    NSCLC
    SCLC
    Colorectal Cancer
    Pancreas Cancer
    TNBC - Triple-Negative Breast Cancer
    DLBCL - Diffuse Large B Cell Lymphoma
    Squamous Cell Carcinoma of Head and Neck

NCT06534762

Zhejiang Provincial People's Hospital

8 April 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.